Sole Source - TPOXX - Combined Synopsis/Solicitation
Closed Solicitation Posted
- Solicitation number
- W911SR-22-Q-0003
- Agency
- ACC Aberdeen Proving Ground Army Contracting Command, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Corvallis, Oregon 97333, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Medical will award a firm-fixed-price sole source contract to SIGA Technologies, Inc. to procure 10,000 doses of the smallpox therapeutic tecovirimat, also known as TPOXX. This procurement is to replenish expiring stock within the Department of Defense stockpile. The contract value is $7,469,964 to purchase the initial 10,000 doses, with an option to purchase an additional 10,000 doses. Proposals are due by March 23, 2022 and award is projected for March 2022, utilizing FY21 procurement funds.
No set-aside designation was used. SIGA Technologies, Inc. is the only incumbent and potential contractor, located in Corvallis, Oregon. They are the exclusive developer of TPOXX, which is the only FDA-approved therapeutic that meets the Department's requirement for treating smallpox infections and developing an indication for post-exposure prophylaxis. The place of performance will be Corvallis, Oregon.
Notice text
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear (JPEO-CBRN) Medical will award a firm-fixed-price Federal Acquisition Regulation (FAR) based sole source contract with SIGA Technologies, Inc. 4575 SW Research Way, Ste 110, Corvallis, OR, 97333 to purchase 10,000 additional doses of a smallpox therapeutic to replenish expiring doses within the
existing Department of Defense (DoD) stockpile with a future option to purchase at least 10,000 more doses to increase the available quantity. The Government projects award for March 2022 and FY21 procurement funds will be used. Supported by an approved justification and approval for other than full and open competition.
Attachments
| File | Type | Posted |
|---|---|---|
| W911SR22Q0003 TPOXX.docx | DOCX document | |
| TPOXX JA 2-9-2022-fully signed-2.10.22.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Sole Source - TPOXX - Combined Synopsis/Solicitation | Solicitation | |
| Sources Sought Notice - TPOXX | Pre-Solicitation | |
| Notice of Intent to Sole Source - TPOXX | Special Notice |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity